5/22/2024 12:20:28 PM - Extended from any sound base and pulling back from its all-time high with today&#39;s 2nd consecutive loss. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.  Through Mar &#39;24 its quarterly earnings growth has been strong and well above the +25% minimum guideline (C criteria). After years of steadily shrinking losses it has shown great earnings growth in FY &#39;22 and &#39;23.<br><hr>5/21/2024 12:12:49 PM - Extended from any sound base and pulling back from its all-time high with today&#39;s loss. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.  Through Mar &#39;24 its quarterly earnings growth has been strong and well above the +25% minimum guideline (C criteria). After years of steadily shrinking losses it has shown great earnings growth in FY &#39;22 and &#39;23.<br><hr>2/29/2024 12:22:11 PM - Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Extended from any sound base and hitting another new all=time high with today&#39;s volume-driven gain. Through Dec &#39;23 is quarterly earnings growth has been strong and well above the +25% minimum guideline (C criteria). After years of steadily shrinking losses it has shown great earnings growth in FY &#39;22 and &#39;23.<br><hr>2/9/2024 12:39:09 PM - Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Extended from any sound base and hitting another new all=time high with today&#39;s big volume-driven gain. Through Dec &#39;23 is quarterly earnings growth has been strong and well above the +25% minimum guideline (C criteria). After years of steadily shrinking losses it has shown great earnings growth in FY &#39;22 and &#39;23.<br><hr>